James F. Sanchez

3.8k total citations
59 papers, 2.4k citations indexed

About

James F. Sanchez is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, James F. Sanchez has authored 59 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Molecular Biology and 17 papers in Pharmacology. Recurrent topics in James F. Sanchez's work include Microbial Natural Products and Biosynthesis (17 papers), Fungal Biology and Applications (14 papers) and CAR-T cell therapy research (11 papers). James F. Sanchez is often cited by papers focused on Microbial Natural Products and Biosynthesis (17 papers), Fungal Biology and Applications (14 papers) and CAR-T cell therapy research (11 papers). James F. Sanchez collaborates with scholars based in United States, Taiwan and Italy. James F. Sanchez's co-authors include Clay C. C. Wang, Yi‐Ming Chiang, Nancy P. Keller, Berl R. Oakley, Hsien-Chun Lo, Amber D. Somoza, Ruth Entwistle, Edyta Szewczyk, Ashley D. Davidson and Kenji Watanabe and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

James F. Sanchez

58 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James F. Sanchez United States	24	1.3k	1.2k	523	364	311	59	2.4k
Saskia Neuteboom United States	23	339 0.3×	1.8k 1.5×	596 1.1×	85 0.2×	310 1.0×	53	2.4k
Michael J. Staver United States	15	907 0.7×	1.8k 1.5×	189 0.4×	313 0.9×	232 0.7×	16	2.2k
Chenwei Lin United States	25	141 0.1×	1.7k 1.4×	666 1.3×	479 1.3×	76 0.2×	54	2.7k
Klaus G. Steube Germany	24	311 0.2×	603 0.5×	243 0.5×	82 0.2×	337 1.1×	53	1.5k
Peter Loidl Austria	39	330 0.3×	3.2k 2.6×	535 1.0×	1.1k 3.0×	35 0.1×	97	3.8k
Akihisa Matsuyama Japan	20	162 0.1×	2.4k 2.0×	411 0.8×	155 0.4×	101 0.3×	55	2.8k
Xinfang Yu China	28	134 0.1×	1.2k 1.0×	533 1.0×	272 0.7×	54 0.2×	53	2.0k
Horst Flotow Singapore	17	132 0.1×	1.1k 0.9×	282 0.5×	128 0.4×	123 0.4×	31	1.8k
Setsuko Kunimoto Japan	19	282 0.2×	871 0.7×	200 0.4×	100 0.3×	223 0.7×	46	1.4k
Charles A. Omer United States	29	191 0.1×	1.5k 1.2×	499 1.0×	175 0.5×	78 0.3×	52	2.1k

Countries citing papers authored by James F. Sanchez

Since Specialization

Citations

This map shows the geographic impact of James F. Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Sanchez more than expected).

Fields of papers citing papers by James F. Sanchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Sanchez. The network helps show where James F. Sanchez may publish in the future.

Co-authorship network of co-authors of James F. Sanchez

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Sanchez. A scholar is included among the top collaborators of James F. Sanchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Sanchez. James F. Sanchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ladbury, Colton, James F. Sanchez, Joycelynne Palmer, et al.. (2024). Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma. American Journal of Clinical Oncology. 47(7). 325–332. 1 indexed citations

Sanchez, James F., Joycelynne Palmer, Timothy W. Synold, et al.. (2023). Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes. eScholarship (California Digital Library). 7(1). 9–27. 1 indexed citations

Wu, Xiwei, Hanjun Qin, Yate‐Ching Yuan, et al.. (2023). Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma. JCI Insight. 8(13). 12 indexed citations

Sanchez, James F., et al.. (2023). Factors that sustain indigenous youth mentoring programs: a qualitative systematic review. BMC Public Health. 23(1). 429–429. 4 indexed citations

Wu, Xiwei, Yate‐Ching Yuan, Hanjun Qin, et al.. (2021). MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma. Journal of Investigative Dermatology. 142(3). 603–612.e7. 14 indexed citations

Song, Joo Y., James F. Sanchez, Chandan Guha, et al.. (2021). Longitudinal Preclinical Imaging Characterizes Extracellular Drug Accumulation After Radiation Therapy in the Healthy and Leukemic Bone Marrow Vascular Microenvironment. International Journal of Radiation Oncology*Biology*Physics. 112(4). 951–963. 5 indexed citations

Nathwani, Nitya, Joycelynne Palmer, Timothy W. Synold, et al.. (2020). Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 20(10). e667–e672. 6 indexed citations

Gunes, Emine Gulsen, Hadas Lewinsky, Domenico Viola, et al.. (2019). CD84: A Potential Novel Therapeutic Target in the Multiple Myeloma Microenvironment. Clinical Lymphoma Myeloma & Leukemia. 19(10). e148–e149.

Querfeld, Christiane, Jasmine Zain, Tijana Jovanović‐Talisman, et al.. (2019). PHASE 1/2 TRIAL OF ANTI‐PD‐LIGAND 1 (DURVALUMAB) +/‐ LENALIDOMIDE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: PRELIMINARY RESULTS OF PHASE 1 AND CORRELATIVE STUDIES. Hematological Oncology. 37(S2). 519–520. 1 indexed citations

10.

Buettner, Ralf, Xiwei Wu, James F. Sanchez, et al.. (2019). Leflunomide Synergizes with Gemcitabine in Growth Inhibition of PC Cells and Impairs c-Myc Signaling through PIM Kinase Targeting. Molecular Therapy — Oncolytics. 14. 149–158. 21 indexed citations

11.

Kumar, Bijender, Indu Nair, Junie Chea, et al.. (2018). 64cu-DOTA-Anti-CD33 PET-CT Imaging for Acute Myeloid Leukemia and Image-Guided Treatment. Blood. 132(Supplement 1). 2747–2747. 1 indexed citations

12.

Sanchez, James F., Jasmine M. Zain, Marshall E. Kadin, et al.. (2017). PD-L1 Is Regulated By Interferon Gamma and Interleukin 6 through STAT1 and STAT3 Signaling in Cutaneous T-Cell Lymphoma. Blood. 130. 1458–1458. 13 indexed citations

13.

Wang, Xiuli, Miriam Walter, Ryan Urak, et al.. (2017). Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma. Clinical Cancer Research. 24(1). 106–119. 149 indexed citations

14.

Rosenzweig, Michael, Ryan Urak, Miriam Walter, et al.. (2017). Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosis. Cytotherapy. 19(7). 861–866. 23 indexed citations

15.

Brown, Christine E., Brenda Aguilar, Renate Starr, et al.. (2017). Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Molecular Therapy. 26(1). 31–44. 226 indexed citations

16.

Querfeld, Christiane, Xiwei Wu, James F. Sanchez, et al.. (2016). The miRNA Profile of Cutaneous T Cell Lymphoma Correlates with the Dysfunctional Immunophenotype of the Disease. Blood. 128(22). 4132–4132. 8 indexed citations

17.

Aldoss, Ibrahim, Monzr M. Al Malki, Tracey Stiller, et al.. (2015). Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 22(3). 575–578. 26 indexed citations

18.

Chiang, Yi‐Ming, James F. Sanchez, Ruth Entwistle, et al.. (2014). Inhibition of Tau Aggregation by Three Aspergillus nidulans Secondary Metabolites: 2,ω-Dihydroxyemodin, Asperthecin, and Asperbenzaldehyde. Planta Medica. 80(1). 77–85. 31 indexed citations

19.

Sanchez, James F., Yi‐Ming Chiang, Edyta Szewczyk, et al.. (2009). Molecular genetic analysis of the orsellinic acid/F9775 genecluster of Aspergillus nidulans. Molecular BioSystems. 6(3). 587–593. 116 indexed citations

20.

Chiang, Yi‐Ming, Edyta Szewczyk, Tania Nayak, et al.. (2008). Molecular Genetic Mining of the Aspergillus Secondary Metabolome: Discovery of the Emericellamide Biosynthetic Pathway. Chemistry & Biology. 15(6). 527–532. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact